BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...

In STEMI-induced cardiogenic shock, a microaxial flow pump can unload the heart by reducing native cardiac output and ...

New 10-year data from the DANAMI-3-PRIMULTI trial show long-term benefits of complete revascularization for patients with ...

Individuals with IBD, especially CD, have an increased risk for myocardial infarction, ischemic heart disease, cerebrovascular accident, and major adverse cardiovascular events.

Myocardial infarction (MI) is an uncommonly suspected cause of morbidity in children. This retrospective case series study was undertaken to ascertain the incidence and etiologies of MI in the ...

A study led by scientists at King's has revealed how the physical orientation of the heart inside the chest dramatically ...

BACKGROUND: Primary aldosteronism (PA), an overt form of renin-independent aldosterone production, leads to a disproportionately high rate of major adverse cardiovascular events (MACEs). Mounting ...

Patients with abnormal findings had worse outcomes down the road. Still unknown is exactly how to modify that risk.

C orFlow Therapeutics is set to initiate a pivotal trial of its CorFlow CoFl system across US hospitals for patients being ...

This case is unique because it documents a rare occurrence of a Type IV stent fracture following percutaneous coronary ...